Skip to main content

Advertisement

SpringerLink
Log in

Prognostic value of CD45 transcriptional expression in head and neck cancer

  • Head and Neck
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Introduction

Tumor-infiltrating lymphocytes (TILs) have a recognized antitumor activity in head and neck squamous cell carcinoma (HNSCC). CD45 is one of the most highly expressed proteins in lymphocytes. We carry out a study to assess the prognostic value of transcriptional expression of CD45 in HNSCC.

Material and methods

We determined the transcriptional expression of CD45 in 160 consecutive HNSCC patients and compared the TIL values according to the CD45 expression.

Results

Five-year disease-free survival for patients with a high transcriptional expression of CD45 (n = 107) was 62.4% and for patients with a low expression (n = 53) it was 36.2% (P = 0.003). Patients with a high expression of CD45 had a better local recurrence-free survival and disease-specific survival. The results of a multivariate analysis showed that patients with a low expression of CD45 had 2.0-fold high risk of recurrence (95% CI 1.2–3.2, P = 0.003). In oropharyngeal carcinomas, HPV-positive tumors showed a higher transcriptional CD45 expression than HPV-negative tumors. Tumors with high CD45 expression had immunohistochemical TIL scores significantly higher than those with low CD45 expression.

Conclusion

According to our results, CD45 expression is a potential marker for tumor outcome in HNSCC patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Whiteside TL (2006) Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention. Semin Cancer Biol 16:3–15

    Article  CAS  PubMed  Google Scholar 

  2. Wallis SP, Stafford ND, Greenman J (2015) Clinical relevance of immune parameters in the tumor microenvironment of head and neck cancers. Head Neck 37:449–459

    Article  PubMed  Google Scholar 

  3. Earl LA, Baum LG (2008) CD45 glycosylation controls T-cell life and death. Immunol Cell Biol 86:608–615

    Article  CAS  PubMed  Google Scholar 

  4. Chew A, Salama P, Robbshaw A, Klopcic B, Zeps N, Platell C, Lawrance IC (2011) SPARC, FOXP3, CD8 and CD45 correlation with disease recurrence and long-term disease-free survival in colorectal cancer. PLoS One 6:e22047

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Wang W, Hodkinson P, McLaren F, Mackean MJ, Williams L, Howie SEM, Wallace WAH, Sethi T (2013) Histologic assessment of tumor-associated CD45(+) cell numbers is an independent predictor of prognosis in small cell lung cancer. Chest 143:146–151

    Article  PubMed  Google Scholar 

  6. León X, Orús C, Quer M (2002) Design, maintenance, and exploitation of an oncologic database for patients with malignanttumors of the head and neck. Acta Otorrinolaringol Esp 53:185–190

    Article  PubMed  Google Scholar 

  7. https://tcga-data.nci.nih.gov/tcga/tcgaHome2.jsp. Accessed 20 March 2017

  8. Jung AC, Guihard S, Krugell S, Ledrappier S, Brochot A, Dalstein V, Job S, de Reynies A, Noël G, Wasylyk B, Clavel C, Abecassis J (2013) CD8-alpha T-cell infiltration in human papillomavirus-related oropharyngeal carcinoma correlates with improved patient prognosis. Int J Cancer 32:E26-36

    Google Scholar 

  9. Berinstein NL, Wolf GT, Naylor PH, Baltzer L, Egan JE, Brandwein HJ, Whiteside TL, Goldstein LC, El-Naggar A, Badoual C, Fridman WH, White JM, Hadden JW (2012) Increased lymphocyte infiltration in patients with head and neck cancer treated with the IRX-2 immunotherapy regimen. Cancer Immunol Immunother 61:771–782

    Article  CAS  PubMed  Google Scholar 

  10. Ward MJ, Thirdborough SM, Mellows T, Riley C, Harris S, Suchak K, Webb A, Hampton C, Patel NN, Randall CJ, Cox HJ, Jogai S, Primrose J, Piper K, Ottensmeier CH, King EV, Thomas GJ (2014) Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer. Br J Cancer 110:489–500

    Article  CAS  PubMed  Google Scholar 

  11. Wansom D, Light E, Thomas D, Worden F, Prince M, Urba S, Chepeha D, Kumar B, Cordell K, Eisbruch A, Taylor J, Moyer J, Bradford C, D’Silva N, Carey T, McHugh J, Wolf G; UM Head Neck SPORE Program (2012) Infiltrating lymphocytes and human papillomavirus-16–associated oropharyngeal cancer. Laryngoscope 122:121–127

    Article  PubMed  PubMed Central  Google Scholar 

  12. Rajjoub S, Basha SR, Einhorn E, Cohen MC, Marvel DM, Sewell DA (2007) Prognostic significance of tumor-infiltrating lymphocytes in oropharyngeal cancer. Ear Nose Throat J 86:506–511

    PubMed  Google Scholar 

  13. Balermpas P, Michel Y, Wagenblast J, Seitz O, Weiss C, Rödel F, Rödel C, Fokas E (2014) Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer. Br J Cancer 110:501–509

    Article  CAS  PubMed  Google Scholar 

  14. Distel LV, Fickenscher R, Dietel K, Hung A, Iro H, Zenk J, Nkenke E, Büttner M, Niedobitek G, Grabenbauer GG (2009) Tumour infiltrating lymphocytes in squamous cell carcinoma of the oro- and hypopharynx: prognostic impact may depend on type of treatment and stage of disease. Oral Oncol 45:e167-174

    Article  Google Scholar 

  15. Zancope E, Costa NL, Junqueira-Kipnis AP, Valadares MC, Silva TA, Leles CR, Mendonça EF, Batista AC (2010) Differential infiltration of CD8 + and NK cells in lip and oral cavity squamous cell carcinoma. J Oral Pathol Med 39:162–167

    Article  CAS  PubMed  Google Scholar 

  16. Watanabe Y, Katou F, Ohtani H, Nakayama T, Yoshie O, Hashimoto K (2010) Tumor-infiltrating lymphocytes, particularly the balance between CD8(+) T cells and CCR4(+) regulatory T cells, affect the survival of patients with oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 109:744–752

    Article  PubMed  Google Scholar 

  17. Näsman A, Romanitan M, Nordfors C, Grün N, Johansson H, Hammarstedt L, Marklund L, Munck-Wikland E, Dalianis T, Ramqvist T (2012) Tumor infiltrating CD8 + and Foxp3 + lymphocytes correlate to clinical outcome and human papillomavirus (HPV) status in tonsillar cancer. PLoS One 7:e38711

    Article  PubMed  PubMed Central  Google Scholar 

  18. Nordfors C, Grün N, Tertipis N, Ährlund-Richter A, Haeggblom L, Sivars L, Du J, Nyberg T, Marklund L, Munck-Wikland E, Näsman A, Ramqvist T, Dalianis T (2013) CD8 + and CD4 + tumour infiltrating lymphocytes in relation to human papillomavirus status and clinical outcome in tonsillar and base of tongue squamous cell carcinoma. Eur J Cancer 49:2522–2530

    Article  CAS  PubMed  Google Scholar 

  19. Russell S, Angell T, Lechner M, Liebertz D, Correa A, Sinha U, Kokot N, Epstein A (2013) Immune cell infiltration patterns and survival in head and neck squamous cell carcinoma. Head Neck Oncol 5:24

    PubMed  PubMed Central  Google Scholar 

  20. Wolf GT, Chepeha DB, Bellile E, Nguyen A, Thomas D, McHugh J; University of Michigan Head and Neck SPORE Program (2015) Tumor infiltrating lymphocytes (TIL) and prognosis in oral cavity squamous carcinoma: a preliminary study. Oral Oncol 51:90–95

    Article  CAS  PubMed  Google Scholar 

  21. Lee YS, Park JY, Cho KJ, Kim SB, Lee SW, Choi SH, Roh JL, Nam SY, Kim SY (2015) Composition of inflammatory cells regulating the response to concurrent chemoradiation therapy for HPV (+) tonsil cancer. Oral Oncol 51:1113–1119

    Article  CAS  PubMed  Google Scholar 

  22. Nguyen N, Bellile E, Thomas D, McHugh J, Rozek L, Virani S, Peterson L, Carey TE, Walline H, Moyer J, Spector M, Perim D, Prince M, McLean S, Bradford CR, Taylor JM, Wolf GT; Head and Neck SPORE Program Investigators (2016) Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma. Head Neck 38:1074–1084

  23. Badoual C, Hans S, Rodriguez J, Peyrard S, Klein C, Agueznay Nel H, Mosseri V, Laccourreye O, Bruneval P, Fridman WH, Brasnu DF, Tartour E (2006) Prognostic value of tumor-infiltrating CD4 + T-cell subpopulations in head and neck cancers. Clin Cancer Res 12:465–472

    Article  CAS  PubMed  Google Scholar 

  24. Pretscher D, Distel LV, Grabenbauer GG, Wittlinger M, Buettner M, Niedobitek G (2009) Distribution of immune cells in head and neck cancer: CD8 + T-cells and CD20 + B-cells in metastatic lymph nodes are associated with favourable outcome in patients with oro- and hypopharyngeal carcinoma. BMC Cancer 9:292

    Article  PubMed  PubMed Central  Google Scholar 

  25. Tabachnyk M, Distel LV, Büttner M, Grabenbauer GG, Nkenke E, Fietkau R, Lubgan D (2012) Radiochemotherapy induces a favourable tumour infiltrating inflammatory cell profile in head and neck cancer. Oral Oncol 48:594–601

    Article  CAS  PubMed  Google Scholar 

  26. Sun DS, Zhao MQ, Xia M, Li L, Jiang YH (2012) The correlation between tumor-infiltrating Foxp3 + regulatory T cells and cyclooxygenase-2 expression and their association with recurrence in resected head and neck cancers. Med Oncol 29:707–713

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Angiology, Vascular Biology and Inflammation, Institute of Biomedical Research (IIB Sant Pau), Barcelona, Spain

    Mercedes Camacho

  2. Otorhinolaryngology Department, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, C/Mas Casanovas, 90, 08041, Barcelona, Spain

    Adriana Agüero, Anna Sumarroca, Jacinto García, Miquel Quer & Xavier León

  3. Pathology Department, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain

    Laura López

  4. Infections and Cancer Laboratory, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), L’Hospitalet de Llobregat, Barcelona, Spain

    Miguel-Ángel Pavón

  5. Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Madrid, Spain

    Miguel-Ángel Pavón & Xavier León

  6. Otorhinolaryngology Department, Hospital Clínic, Barcelona, Spain

    Francesc-Xavier Avilés-Jurado

Authors
  1. Mercedes Camacho
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Adriana Agüero
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anna Sumarroca
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Laura López
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Miguel-Ángel Pavón
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Francesc-Xavier Avilés-Jurado
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jacinto García
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Miquel Quer
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Xavier León
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xavier León.

Ethics declarations

Funding

This work was supported by the Plan Estatal de I + D + I of the Instituto de Salud Carlos III (FIS PI14/01819 to XL, FIS PI15/02047 to FXAJ). Fondo Europeo de Desarrollo Regional (FEDER), A Way to Build Europe.

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Due to the retrospective type of the study no formal consent was required.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 196 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Camacho, M., Agüero, A., Sumarroca, A. et al. Prognostic value of CD45 transcriptional expression in head and neck cancer. Eur Arch Otorhinolaryngol 275, 225–232 (2018). https://doi.org/10.1007/s00405-017-4806-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-017-4806-2

Keywords

Search

Navigation